Search Results

Effects of 12-Month Tadalafil Therapy for Erectile Dysfunction on Couple Relationships: Results from the DETECT Study

Authors: Verheyden, Benny; Roumeguère, Thierry; Bitton, Alain; Belger, Mark; Schmitt, Henry

Source: The Journal of Sexual Medicine, Volume 6, Number 12, December 2009 , pp. 3458-3468(11)

Publisher: Blackwell Publishing

CASE REPORT: Hair Analysis to Demonstrate Administration of Sildenafil to a Woman in a Case of Drug-Facilitated Sexual Assault

Authors: Kintz, Pascal; Evans, Julie; Villain, Marion; Chatterton, Craig; Cirimele, Vincent

Source: Journal of Analytical Toxicology, Volume 33, Number 8, October 2009 , pp. 553-556(4)

Publisher: Preston Publications

Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension

Authors: Pepke-Zaba, Joanna; Beardsworth, Anthony; Chan, Melanie; Angalakuditi, Mallik

Source: Current Medical Research and Opinion, Volume 25, Number 10, October 2009 , pp. 2479-2485(7)

Publisher: Informa Healthcare

Phosphodiesterase Type 5 Inhibitors Facilitate Noncontact Erections in Male Rats: Site of Action in the Brain and Mechanism of Action

Authors: Sanna, Fabrizio; Succu, Salvatora; Boi, Antonio; Melis, Maria Rosaria; Argiolas, Antonio

Source: The Journal of Sexual Medicine, Volume 6, Number 10, October 2009 , pp. 2680-2689(10)

Publisher: Blackwell Publishing

Timing of Dose Relative to Sexual Intercourse Attempt in Previous Sildenafil Citrate Users Treated with Tadalafil: A Geographical Comparison from a Single Arm, Open-Label Study

Authors: Rubio-Aurioles, Eusebio; Glina, Sidney; Abdo, Carmita H.N.; Hernandez-Serrano, Ruben; Rampazzo, Claudia; Sotomayor, Mariano; West, Teena M.; Gallagher, Gabrielle L.; Lenero, Enrique

Source: The Journal of Sexual Medicine, Volume 6, Number 10, October 2009 , pp. 2836-2850(15)

Publisher: Blackwell Publishing

Sildenafil/tadalafil: Sudden sensorineural hearing loss: 2 case reports

Source: Reactions, Volume 1, Number 1272, 2009-10-03 , pp. 28-29(2)

Publisher: Adis International

Sclerosing lymphangitis of the penis after coadministration of tadalafil and fluconazole

Authors: Guarneri, C.; Polimeni, G.

Source: Clinical & Experimental Dermatology, Volume 34, Number 7, October 2009 , pp. e225-e226(1)

Publisher: Blackwell Publishing

Editorial [Hot topic: Phosphodiesterase-5 Inhibitors and their Use in the Treatment of Urological Conditions (Executive Editor: Perimenis Petros)]

Author: Petros, Perimenis

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3463-3463(1)

Publisher: Bentham Science Publishers

PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile

Authors: Kouvelas, D.; Goulas, A.; Papazisis, G.; Sardeli, C.; Pourzitaki, C.

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3464-3475(12)

Publisher: Bentham Science Publishers

Phosphodiesterase Type 5 Inhibitors: Unmet Needs

Authors: Hatzimouratidis, K.; Hatzichristou, D. G.

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3476-3485(10)

Publisher: Bentham Science Publishers

Phosphodiesterase Type 5 Inhibitors for the Management of Erectile Dysfunction: Preference and Adherence to Treatment

Authors: Al-Shaiji, T. F.; Brock, G. B.

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3486-3495(10)

Publisher: Bentham Science Publishers

PDE5 Inhibitors in Non-Urological Conditions

Authors: Vlachopoulos, C.; Terentes-Printzios, D.; Ioakeimidis, N.; Rokkas, K.; Stefanadis, C.

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3521-3539(19)

Publisher: Bentham Science Publishers

Phosphodiesterase-5 Inhibitors: Future Perspectives

Authors: Konstantinos, Giannitsas; Petros, Perimenis

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3540-3551(12)

Publisher: Bentham Science Publishers

Health Canada issues alerts for multiple products

Source: Reactions, Volume 1, Number 1269, 2009-09-12 , pp. 3-3(1)

Publisher: Adis International

2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 2: Updates on Optimal Utilization for Sexual Concerns and Rare Toxicities in This Class (CME)

Author: Shindel, Alan W.

Source: The Journal of Sexual Medicine, Volume 6, Number 9, September 2009 , pp. 2352-2364(13)

Publisher: Blackwell Publishing

The ENDOTRIAL Study: A Spontaneous, Open-Label, Randomized, Multicenter, Crossover Study on the Efficacy of Sildenafil, Tadalafil, and Vardenafil in the Treatment of Erectile Dysfunction

Authors: Jannini, Emmanuele A.; Isidori, Andrea M.; Gravina, Giovanni Luca; Aversa, Antonio; Balercia, Giancarlo; Bocchio, Massimo; Boscaro, Marco; Carani, Cesare; Corona, Giovanni; Fabbri, Andrea; Foresta, Carlo; Forti, Gianni; Francavilla, Sandro; Granata, Antonio R.M.; Maggi, Mario; Mansani, Riccardo; Palego, Pierfrancesco; Spera, Giovanni; Vetri, Mario; Lenzi, Andrea

Source: The Journal of Sexual Medicine, Volume 6, Number 9, September 2009 , pp. 2547-2560(14)

Publisher: Blackwell Publishing

Health Canada issue Foreign Product Alerts for three products

Source: Reactions, Volume 1, Number 1264, 2009-08-08 , pp. 3-3(1)

Publisher: Adis International

The burden and extent of comorbid conditions in patients with erectile dysfunction

Author: Hackett, G.

Source: International Journal of Clinical Practice, Volume 63, Number 8, August 2009 , pp. 1205-1213(9)

Publisher: Blackwell Publishing

Toward a new `EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction

Authors: Sadovsky, R.; Brock, G. B.; Gutkin, S. W.; Sorsaburu, S.

Source: International Journal of Clinical Practice, Volume 63, Number 8, August 2009 , pp. 1214-1230(17)

Publisher: Blackwell Publishing

Five-year experience with tadalafil in the UK: an effective treatment for erectile dysfunction

Author: Dinsmore, W.

Source: International Journal of Clinical Practice, Volume 63, Number 8, August 2009 , pp. 1231-1236(6)

Publisher: Blackwell Publishing